Phenomenex's Clarity OTX oligonucleotide extraction kit provides an advanced approach to the isolation of RNA- and DNA-based therapeutics and their metabolites from biological matrices.
This solid phase extraction (SPE) method removes a major roadblock in oligonucleotide drug development, according to Michael McGinley, bioseparations product manager.
Unlike previous oligonucleotide therapeutic isolation techniques that use labour-intensive, low-throughput, liquid/liquid extraction methods, Clarity OTX isolates oligonucleotide therapeutics and their metabolites in just 15 minutes.
Clarity OTX extraction kits effectively remove cell debris that can mask the oligo therapeutic or metabolite of interest and interfere with low-level MS detection.